Washington University’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Washington University’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-291,253	Closed	-$7.02M	–	12
2023 Q1	$7.02M	Buy	+291,253	New	+$3.65M	1.85%	7

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Washington University's PRVB Position: Q2 2023 in Review

Washington University sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 291,253 shares — an estimated $7.02M sold.

Washington University first reported a position in PRVB in Q1 2023 and held it in 1 quarter. The position peaked at $7.02M in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Washington University reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Washington University sold 291,253 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $7.02M.
Washington University first reported a position in Provention Bio, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
Washington University's Provention Bio, Inc. Common Stock position peaked at $7.02M in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Washington University's 13F filing for Q2 2023, filed 9 Aug 2023.